help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on November 7, 2007, doi:10.1165/rcmb.2007-0177OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
2007-0177OCv1
38/4/423    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Livraghi, A.
Right arrow Articles by Ribeiro, C. M. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Livraghi, A.
Right arrow Articles by Ribeiro, C. M. P.
American Journal of Respiratory Cell and Molecular Biology. Vol. 38, pp. 423-434, 2008
© 2008 American Thoracic Society
DOI: 10.1165/rcmb.2007-0177OC

Modelling Dysregulated Na+ Absorption in Airway Epithelial Cells with Mucosal Nystatin Treatment

Alessandra Livraghi1, Marcus Mall2, Anthony M. Paradiso1,{dagger}, Richard C. Boucher1,3 and Carla M. Pedrosa Ribeiro1,3

1 Cystic Fibrosis/Pulmonary Research and Treatment Center, and 3 Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and 2 Department of Pediatrics III, Pediatric Pulmonology and Cystic Fibrosis Center, University of Heidelberg, Heidelberg, Germany

Correspondence and requests for reprints should be addressed to Alessandra Livraghi, Ph.D., University of North Carolina at Chapel Hill, Cystic Fibrosis/Pulmonary Research and Treatment Center, CB#7248 Thurston Bowles Bldg., Room # 6029, Chapel Hill, NC 27599. E-mail: alessandra_livraghi{at}med.unc.edu

In cystic fibrosis (CF), the absence of functional CFTR leads to dysregulated Na+ absorption across airway epithelia. We established an in vitro model of dysregulated Na+ absorption by treating polarized normal human bronchial epithelial cells (HBEs) with nystatin (Nys), a polyene antibiotic that enables monovalent cations to permeate biological membranes. Acute mucosal Nys produced a rapid increase in short circuit current (Isc) that reflected increased transepithelial Na+ absorption and required Na+/K+ATPase activity. The acute increase in Isc was associated with increased mucosal liquid absorption. Prolonged mucosal Nys treatment resulted in sustained Na+ hyperabsorption, associated with increased mucosal liquid absorption in comparison with naïve (nontreated, kept under air–liquid interface conditions) or vehicle-treated cultures. Nys treatment was not toxic. Increased lactate accumulation in Nys-treated culture media suggested a higher metabolic rate associated with the higher energy demand for Na+ transport. After chronic Nys treatment, the increased Isc was rapidly lost when the cultures were mounted in Ussing chambers, indicating that Nys could be rapidly removed from the apical membrane. Importantly, chronic Nys treatment promoted sustained mucosal liquid depletion and caused mucus dehydration, compaction, and adhesion to the apical surface of Nys-treated cultures. We conclude that mucosal Nys treatment of HBEs provides a simple in vitro model to recapitulate the Na+ and volume hyperabsorptive features of CF airway epithelia.

Key Words: nystatin • Na+ hyperabsorption • airway surface liquid dehydration • mucus adherence • cystic fibrosis


CLINICAL RELEVANCE

Our model recapitulates two key features of cystic fibrosis (CF) airways: abnormal Na+ transport and cell surface accumulation of dehydrated mucus. This model may be used to characterize interactions in a milieu resembling CF airways.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2008 American Thoracic Society.